OrbiMed Capital GP V LLC's Net Worth
$0
Who is OrbiMed Capital GP V LLC?
OrbiMed Capital GP V LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., RHYTHM PHARMACEUTICALS, INC., PMV Pharmaceuticals, Inc., SI-BONE, Inc., Intellia Therapeutics, Inc., Inspire Medical Systems, Inc., Aadi Bioscience, Inc., Tricida, Inc., Adaptimmune Therapeutics PLC, ARMO BioSciences, Inc., Loxo Oncology, Inc., Nabriva Therapeutics AG, Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Compass Therapeutics, Inc., and Corvus Pharmaceuticals, Inc..
SEC CIK
OrbiMed Capital GP V LLC's CIK is 0001615374
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.71% | -19.58K |
$30.43 | -$595,768.40 | 2.75M |
May 22
| |||
Form 4
| -4.54% | -131.64K |
$30.88 | -$4,065,439.72 | 2.77M |
May 18 - May 21
| |||
Form 4
|
∞
| 2.9M |
$17.00 |
—
| 2.9M |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.66M |
$18.00 |
—
| 2.66M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aerpio Pharmaceuticals, Inc. (AADI) Snapshot price: $1.82
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$1.46 | -$21,400.00 |
0
|
Dec 8
| |||
Form 4
| +17.60% | 777.5K |
$3.85 | $2,993,375.00 | 5.19M |
Jun 28
| |||
Form 4
| +20.88% | 763K |
$5.00 | $3,814,975.00 | 4.42M |
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.09
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.38% | -18.70K |
$13.56 | -$253,631.00 | 4.9M |
Jun 4 - Jun 6
| |||
Form 4
| -3.36% | -171.00K |
$13.51 | -$2,310,420.00 | 4.92M |
May 30 - Jun 1
| |||
Form 4
| -0.20% | -10.30K |
$13.50 | -$139,050.00 | 5.09M |
May 14
| |||
Form 4
| -17.04% | -1.05M |
$11.50 | -$12,053,729.99 | 5.1M |
Mar 27 - Mar 29
| |||
Form 4
| +24.01% | 1.19M |
$4.20 | $4,999,999.20 | 6.15M |
Mar 27
| |||
Form 4
| +6.11% | 1.71M |
$10.42 | $17,849,568.00 | 29.75M |
May 20 - May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Loxo Oncology, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.99% | -250.00K |
$82.50 | -$20,625,000.00 | 941K |
Dec 8
| |||
Form 4
| -18.31% | -267.00K |
$75.00 | -$20,025,000.00 | 1.19M |
Nov 22
| |||
Form 4
| -15.63% | -270.00K |
$74.26 | -$20,051,388.82 | 1.46M |
Nov 16
| |||
Form 4
| -20.58% | -447.86K |
$26.96 | -$12,074,224.72 | 1.73M |
Aug 10
| |||
Form 4
|
∞
| 2.18M |
$13.00 |
—
| 2.18M |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |